Dr. Forsyth has a strong interest in malignant, invasive glioma brain tumors. He is currently investigating several tumor-inhibiting agents in Phase I clinical trials. One of his first priorities at Moffitt is to develop a neural tumor stem cell lab to expand research opportunities in novel therapeutic cancer-fighting drugs. Currently, he has 10 active grants funding his studies.